The future of genomics in Ireland – focus on genomics for health [version 1; peer review: 2 approved]

• Main Authors: Cathal Seoighe, Adrian P. Bracken, Patrick Buckley, Peter Doran, Robert Green, Sandra Healy, David Kavanagh, Elaine Kenny, Mark Lawler, Maeve Lowery, Derek Morris, Darrin Morrissey, James J. O'Byrne, Denis Shields, Owen Smith, Charles A. Steward, Brian Sweeney, Walter Kolch
• Format: Article
• Language: English
• Published: F1000 Research Ltd 2020-12-01
• Series: HRB Open Research
• Online Access: https://hrbopenresearch.org/articles/3-89/v1

Genomics is revolutionizing biomedical research, medicine and healthcare globally in academic, public and industry sectors alike. Concrete examples around the world show that huge benefits for patients, society and economy can be accrued through effective and responsible genomic research and clinical applications. Unfortunately, Ireland has fallen behind and needs to act now in order to catch up. Here, we identify key issues that have resulted in Ireland lagging behind, describe how genomics can benefit Ireland and its people and outline the measures needed to make genomics work for Ireland and Irish patients. There is now an urgent need for a national genomics strategy that enables an effective, collaborative, responsible, well-regulated, and patient centred environment where genome research and clinical genomics can thrive.  We present eight recommendations that could be the pillars of a national genomics health strategy.